Invenia Group reposted this
Global Scientific Headhunter - Specialising in Emerging Technology e.g. Single Cell, Spatial Biology, Organoids etc.
𝐈𝐧 𝐉𝐮𝐧𝐞, 𝐨𝐯𝐞𝐫 $𝟏𝟓 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐰𝐚𝐬 𝐫𝐚𝐢𝐬𝐞𝐝 𝐛𝐲 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐢𝐧 𝐭𝐡𝐞 𝐁𝐢𝐨𝐭𝐞𝐜𝐡 𝐚𝐧𝐝 𝐁𝐢𝐨𝐩𝐡𝐚𝐫𝐦𝐚 𝐒𝐩𝐚𝐜𝐞. I have put together a summary of the money raised below 👇🏻👇🏻 𝗞𝗲𝘆 𝗳𝗶𝗻𝗱𝗶𝗻𝗴𝘀: 💰The largest amount of money raised was by Novartis who raised $2.49 billion in Post-IPO Debt 💰The largest amount raised by a private company was by Curie.Bio with a massive $380 million raised in its Series A funding round. 💰$2.94 billion was raised between Pre-Seed and Series E funding rounds. Companies in the article include: Cypris Therapeutics, Inc., Citizen Labs, ŌGI Bio, Ability Biologics, TwoStep Therapeutics, EpilepsyGTx, Waypoint Bio, EvolutionaryScale, Alida Biosciences, Moleculent, Amber Therapeutics, GPN Vaccines, Envisagenics, Interius BioTherapeutics, Enveda Biosciences, Santa Ana Bio, Inc., Frontier Medicines, BillionToOne, Formation Bio, Metabolon, Inc., Calico Biosystems, Fuse Diagnostics, Prompt Diagnostics, Nuclera, Mustang Bio, TME Pharma, ANGLE, Annexon Biosciences, Avidity Biosciences, Inc., Grifols, Novartis and many more!